Efficacy of fluorouracil combined with paclitaxel and oxaliplatin for the treatment of advanced gastric signet ring cell carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-6)

Sum=29

Mar 27, 2025 (publication date) through Feb 24, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Surg. Mar 27, 2025; 17(3): 94286
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.94286

Table 4 Clinical characteristics of 85 patients with advanced gastric signet ring cell carcinoma, n (%)

ECOG: Eastern Cooperative Oncology Group.

Citation: Liu M, Feng B, He N, Yan R, Qin J. Efficacy of fluorouracil combined with paclitaxel and oxaliplatin for the treatment of advanced gastric signet ring cell carcinoma. World J Gastrointest Surg 2025; 17(3): 94286
URL: https://www.wjgnet.com/1948-9366/full/v17/i3/94286.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.94286